Botox
Botulinum toxin type A, commonly known as Botox®, functions as a neurotoxin that inhibits muscle contractions by blocking nerve signals. The treatment has been used medically for decades and received FDA cosmetic approval in 2002.
These injections have grown increasingly popular due to high satisfaction rates and ease of administration, now representing a major alternative to surgical procedures. The treatment targets wrinkles—particularly in the upper face—by preventing muscle contractions that create facial lines.
Botox Facial
The Botox® facial, alternatively called Botox® microdosing, merges microneedling’s minimally invasive approach with Botox®’s skin-tightening properties. A medical professional injects botulinum toxin type A through microneedles along epidermis channels. The neurotoxin tightens skin temporarily without affecting facial muscles. This treatment suits individuals seeking subtle, temporary, non-invasive corrections to fine lines and wrinkles.
Results typically appear within 24–72 hours, though some patients require five or more days for complete effects. Full results take time to develop. Once initial swelling and redness subside, visible improvements occur more rapidly.